These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 21761157)
1. Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2. Ma X; Kundu N; Collin PD; Goloubeva O; Fulton AM Breast Cancer Res Treat; 2012 Apr; 132(3):1001-8. PubMed ID: 21761157 [TBL] [Abstract][Full Text] [Related]
2. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4. Holt DM; Ma X; Kundu N; Collin PD; Fulton AM J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906 [TBL] [Abstract][Full Text] [Related]
3. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells. Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation. Takahashi T; Uehara H; Ogawa H; Umemoto H; Bando Y; Izumi K Oncotarget; 2015 Mar; 6(7):4829-44. PubMed ID: 25638159 [TBL] [Abstract][Full Text] [Related]
5. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts. Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. Majumder M; Xin X; Liu L; Girish GV; Lala PK Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes. Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043 [TBL] [Abstract][Full Text] [Related]
8. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281 [TBL] [Abstract][Full Text] [Related]
10. T cell-intrinsic prostaglandin E Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220 [TBL] [Abstract][Full Text] [Related]
11. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells. Park SY; Kim YH; Kim Y; Lee SJ Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811 [TBL] [Abstract][Full Text] [Related]
12. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide. Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956 [TBL] [Abstract][Full Text] [Related]
14. Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasis. Attoub S; Arafat K; Gélaude A; Al Sultan MA; Bracke M; Collin P; Takahashi T; Adrian TE; De Wever O PLoS One; 2013; 8(1):e53087. PubMed ID: 23308143 [TBL] [Abstract][Full Text] [Related]
15. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone promoted gastric cancer growth through prostaglandin E receptor (EP2 and EP4) in vivo and in vitro. Shin VY; Jin HC; Ng EK; Cho CH; Leung WK; Sung JJ; Chu KM Cancer Sci; 2011 May; 102(5):926-33. PubMed ID: 21261791 [TBL] [Abstract][Full Text] [Related]
16. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle. Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts. Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis. Ma X; Kundu N; Rifat S; Walser T; Fulton AM Cancer Res; 2006 Mar; 66(6):2923-7. PubMed ID: 16540639 [TBL] [Abstract][Full Text] [Related]